Clinical Trial Update: The Prism Adaptation Study (PAS) [Phase 3]

View source ↗

Summary

The Prism Adaptation Study (PAS), a Phase 3 clinical trial for esotropia, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esotropia

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Esotropia | Phase 3 | Status: COMPLETED